Bausch Health Companies Inc (BHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $3.13B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bausch Health Companies Inc (BHC) Competitors
The companies most similar to Bausch Health Companies are Prestige Brand Holdings (PBH), BioCryst Pharmaceuticals (BCRX) and Perrigo Company (PRGO). Bausch Health Companies trades at 1.7x earnings, against a median of 11.7x for the 10 of these companies with a P/E. By market cap, Bausch Health Companies ranks 4th of the 13 companies on this page; Lantheus Holdings (LNTH) is the largest at $6.64B.
Peer Comparison
BHC's ROIC of 6.3% is below the peer median of 11.7%, and its revenue growth of 9.7% is below the median of 13.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies (BHC) | $3.13B | 1.7x | 0.3x | -7.6% | 6.3% | 9.7% | 0.00% |
| Prestige Brand Holdings Inc (PBH) | $2.19B | 10.7x | 2.0x | 13.3% | 5.0% | 22.7% | 0.00% |
| BioCryst Pharmaceuticals Inc (BCRX) | $1.96B | 4.4x | 2.0x | -37.4% | 24937.1% | 13.1% | 0.00% |
| Perrigo Company PLC (PRGO) | $2.25B | 7.0x | 0.6x | -43.3% | -26.3% | -5.2% | 7.17% |
| HUTCHMED DRC (HCM) | $2.59B | N/A | 4.7x | 3.3% | -2.4% | 0.2% | 0.00% |
| Indivior PLC Ordinary Shares (INDV) | $4.28B | 6.6x | 2.4x | 32.8% | 109.0% | 13.4% | 0.00% |
| Lantheus Holdings Inc (LNTH) | $6.64B | 17.9x | 4.5x | 17.3% | 14.8% | 1.5% | 0.00% |
| Hims Hers Health Inc (HIMS) | $4.62B | N/A | 1.5x | -6.7% | -11.1% | 48.6% | 0.00% |
| Xeris Pharmaceuticals Inc (XERS) | $3.04B | 139.2x | 8.2x | -1.8% | 15.5% | 44.2% | 0.00% |
| Eton Pharmaceuticals Inc (ETON) | $1.84B | 36.7x | 13.0x | 35.3% | 37.0% | 157.9% | 0.00% |
| Phibro Animal Health Corporation (PAHC) | $1.46B | 10.7x | 0.9x | 6.7% | 11.7% | 6.3% | 1.37% |
| Pacira BioSciences, Inc. (PCRX) | $1.46B | 20.0x | 2.0x | 5.1% | 4.2% | -1.6% | 0.00% |
| Supernus Pharmaceuticals, Inc. (SUPN) | $1.52B | 12.7x | 2.0x | 32.8% | N/A | 13.4% | 0.00% |
| Peer median | $2.22B | 11.7x | 2.0x | 5.9% | 11.7% | 13.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Bausch Health Companies, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Prestige Brand Holdings Inc (PBH) | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States... | PBH competitors |
| BioCryst Pharmaceuticals Inc (BCRX) | BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. | BCRX competitors |
| Perrigo Company PLC (PRGO) | Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals. | PRGO competitors |
| HUTCHMED DRC (HCM) | HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. | |
| Indivior PLC Ordinary Shares (INDV) | Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence... | |
| Lantheus Holdings Inc (LNTH) | Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment... | LNTH competitors |
| Hims Hers Health Inc (HIMS) | Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. | HIMS competitors |
| Xeris Pharmaceuticals Inc (XERS) | Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. | XERS competitors |
| Eton Pharmaceuticals Inc (ETON) | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. | ETON competitors |
| Phibro Animal Health Corporation (PAHC) | Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily... | PAHC competitors |
| Pacira BioSciences, Inc. (PCRX) | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United... | PCRX competitors |
| Supernus Pharmaceuticals, Inc. (SUPN) | Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases... | SUPN competitors |
Frequently Asked Questions About BHC
Who are Bausch Health Companies' main competitors?
The companies most similar to Bausch Health Companies include Prestige Brand Holdings (PBH), BioCryst Pharmaceuticals (BCRX), Perrigo Company (PRGO), HUTCHMED DRC (HCM) and Indivior PLC Ordinary Shares (INDV), listed from the closest match.
Who is Bausch Health Companies' biggest competitor?
Lantheus Holdings (LNTH) is the largest of the similar companies at $6.64B; Prestige Brand Holdings (PBH) is the closest match by business profile, size, sector and industry.
How does BHC stock compare with its competitors?
BHC's P/E is 1.7x against a peer median of 11.7x; its P/S is 0.3x against a peer median of 2.0x; its net margin is -7.6% against a peer median of 5.9%.
Which of Bausch Health Companies' competitors pays a higher dividend?
Bausch Health Companies pays no dividend. Perrigo Company (PRGO) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.
Is Bausch Health Companies bigger than its competitors?
No. Bausch Health Companies is 4th by market cap among the 13 companies on this page; the largest is Lantheus Holdings (LNTH) at $6.64B.
BHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors